NUZ 2.50% 19.5¢ neurizon therapeutics limited

Clinical Trials Interview June 2022, page-10

  1. 2,753 Posts.
    lightbulb Created with Sketch. 1499
    Agree. Its not a real saving when it comes at the cost of progress. Also, how do they reach this conclusion this long after deciding to do human covid trials. Surely the decision to only do one phase 1 could have been made earlier? Seems more like a oh shit moment. We are running out of cash and dare not ask share holders incase we appear to be even more incompetent.

    Roger constantly mentioning being in talks with interested vet parties, covid trial sites, human cancer trial sites....it is clear 'we are in talks' is code for we are not getting anywhere and are spinning our wheels.

    Roger how about getting back to Aus. How about management all take a pay haircut until you deliver something for shareholders.

    Lets face it covid trials will blow into next year, the dog trial wont produce anything commercial this year.


    Its ironic the only trial to proceed on clearish timeline is the MND. Now some will say because of the funding. Id say more likely because there is a professional organisation driving it and setting expectations...and its not PAA. Remember not long ago Sam said clearly we were fully funded for all planned trials...

    Now we wait to hear about Roger being in talks with willing rats for the covid trial, apparently there are at least 4 rats in the country who have ahown an interest. But we need to finds willing clinics in Afghanistan or somewhere first...

 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $94.89M
Open High Low Value Volume
20.0¢ 20.3¢ 19.5¢ $124.5K 628.4K

Buyers (Bids)

No. Vol. Price($)
2 2791 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 62424 2
View Market Depth
Last trade - 15.39pm 01/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.